Financial Year |
March 31 2023 |
Monetary Funds |
474,022,977.41 |
Held-for-trading Financial Assets |
130,627,530.15 |
Notes Receivable |
13,580,398.08 |
Accounts Receivable |
353,355,121.11 |
Advances to Suppliers |
862,453.13 |
Other Receivables |
15,974,800.07 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
146,794,481.52 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
13,709,846.25 |
Total Current Assets |
1,148,927,607.72 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
7,802,251.81 |
Investment Properties |
-- |
Fixed Assetes |
73,576,435.60 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
9,726,552.94 |
R&D expenses |
-- |
Goodwill |
45,823,052.01 |
Long-Term Deferred and Prepaid Expenses |
12,306,727.69 |
Deferred Income Tax Assets |
10,056,930.11 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
198,995,161.35 |
Total Assets |
1,347,922,769.07 |
Short-Term Loans |
-- |
Trading Financial liabilities |
2,400,000.00 |
Notes Payable |
-- |
Accounts Payable |
29,603,709.67 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
47,684,663.22 |
Taxes Payable |
17,457,664.99 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
1,324,484.28 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
12,981,968.99 |
Other Current Liabilities |
2,210,934.29 |
Sub-Total of Current Liabilities |
139,923,618.09 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
294,293.65 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
26,661,645.80 |
Total Liabilities |
166,585,263.89 |
Paid-In Capital(Or Share Stock) |
143,774,714.00 |
Capital Surplus |
533,330,229.86 |
Surplus Reserve |
59,731,461.73 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
409,920,215.46 |
Minority Stockholder's Interest |
34,243,168.69 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,147,094,336.49 |
Owner's Equity(Stockholder's Equity) |
1,181,337,505.18 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,347,922,769.07 |